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The appearance of multicellular systems was associated to the de-
velopment of the nervous and endocrine systems, that ensure chem-
ical signaling between adjacent and distant cells [1–5]. In turn, proper
signalling by these systems to the multicellular organism has im-
posed the development of signaling units sizably larger than the uni-
cellular exocrine systems, which are considered their primordial
precursors [5–9]. Thus, most of the vital endocrine functions of ani-
mals are now dependent on the proper functioning of multicellular
assemblies of secretory cells, whether in endocrine glands or special-
ized nervous regions, which implies the existence of systems coordi-
nating the function of the hormone-producing cells. With evolution,
such coordination systems have developed in a complex network, in
which signals diffusing in the intercellular spaces interplay with the
signalling cascades dependent on the surface proteins that concen-
trate at cell contacts [10–12]. Thus, individual hormone-producing
cells sense the state of activity of their neighbors and regulate, ac-
cordingly, their own level of functioning. In vertebrates, a consistent
feature of this network are the cell-to-cell channels made of connexin
proteins [10–17]. As compared to other forms of cell-to-cell commu-
nication, connexin-dependent cell-to-cell coupling achieves a rapid
intercellular equilibration of electrochemical gradients of both cyto-
plasmic ions and molecules, which may be crucial for hormone secre-
tion [10–19]. In turn, this equilibration ensures the recruitment and
coordination of cells which, taken individually, would otherwise
function asynchronously [10–19]. Although secretory cells of a given
type are generally considered to be similar, ample evidence indicate
that they actually differ in several respects, including the ability to
biosynthesize, store and release hormones [10–23], still function as
homogeneous populations when integrated by coupling. Thus, a
large body of circumstantial evidence has accumulated, indicating that
gap junctions are required for the ﬁne regulation of the biosynthesis,
storage and release of various hormones, as well as for their proper ac-
tion on target cells [10–19]. Conversely, several hormones have now
been documented to contribute to the control of connexin expression
and function. More intriguingly, recent work implies that connexin
signaling may also be involved between selected endocrine cells, and
their cognate, closely associated target cells, a hitherto unsuspected
mechanism for the two-way interaction between signaling and effector
cells.
Here, we have reviewed this body of evidence, with particular regard
to the studies which have investigated the connexin-dependent signal-
ling of vertebrate endocrine cells. The goal was not to provide an in-depth, comprehensive review of the abundant information gathered on
the topic in all endocrine glands, rather to stress on recent developments,
speciﬁcally when in vivo evidence is available. Readers are referred to
previous reviews [10–19], for earlier publications on the topic.
2. Connexins and hormone-producing cells
The hormone-producing cells of most endocrine glands, of secretory
central nervous system nuclei, and of their putative precursor phero-
mone glands, usually express one or more connexins of either the α
or the γ group (Table 1). Cx43 is the most widespread isoform. A few
endocrine cells, including most neurosecretory neurons, have selected
Cx36, whereas Cx40 is so far restricted to the renin-producing cells of
kidney (Table 1). With the notable exception of the thyroid, which em-
bryologically develops as an exocrine gland and maintains throughout
the life an architectural organization reminiscent of this primordial exo-
crine function [5,24], no endocrine cell has yet been shown to express
Cx32, eventhough a few of these cells have selected Cx26, another con-
nexin of the β group (Table 1). Conversely, the parenchymal cells of
exocrine glands express various combinations of β connexins, typically
Cx32 [5]. This different connexin selection is under transcriptional con-
trol. Thus, the 5' regulatory region of the human Gjd2, contains a region
sufﬁcient to restrict the expression of Cx36 to insulin-secreting cells and
neurons. Within this region, a conserved neuron-restrictive silencer el-
ement binds the NRSF/REST factor, which functions as a potent repres-
sor of neuronal genes. NRSF/REST iswidely expressed inmost cell types,
but insulin-secreting cells and neurons, and its ectopic expression re-
duces that of Cx36 in insulin-producing cells [25]. Also, mice lacking
the basic helix-loop-helix transcription factor Mist1, which is normally
expressed in most exocrine cell types, feature pancreatic acini with al-
tered architecture and function, due, at least in part, to a transcriptional
down regulation of Gjb1 and Cx32 [26].
The reason why different connexin species have been selected by
different types of endocrine cells cannot be directly related to either
the embryological origin, the developmental time or the architecture
of the adult glands. It cannot be related either to the biochemical na-
ture of the hormones produced by each gland, the rate of their secre-
tion and the control of their release and biosynthesis (Table 1).
However, since different connexins form channels with distinct con-
ductance, permeability and regulatory characteristics [10,18,27–30],
it is plausible that, during evolution, (neuro)endocrine cells selected
the sets of channels that, by favoring the intercellular exchange of
speciﬁc signals while preventing the diffusion of others, better ﬁtted
the requirements of their own secretory machinery.
Table 1
Connexins of vertebrate (neuro)endocrine glands.
Type of secretion Gland Cell Hormone Connexin isoform Species Reference
Endocrine Hypothalamus Neurons GnRH Cx43, Cx32
Cx36
Rat
Mouse
[41,42]
[37]
Vasopressin Cx43 Mouse [40]
Oxytocin Cx32 Rat [59]
Pineal Pinealocytes Melatonin, serotonin Cx26, Cx32 Rat [60]
Pituitary Acidophil GH, prolactin, Cx43, Cx26 Rat [24,65]
Thyroid Follicular T3, T4 Cx43, Cx32, Cx26 Rat [24,133]
C Calcitonin Cx43 Rat [24]
Parathyroid Principal Parathormone Cx43 Rat [24]
Pancreas Beta Insulin Cx36
Cx36
Rat, mouse
Human
[24,85,335]
[75]
Kidney Myoepithelial Renin Cx40, Cx37, Cx45
Cx40, Cx37
Mouse, rat
Human
[154,164]
[155]
Adrenal Medullary Epinephrine
Norepinephrine
Cx36, Cx43
Cx36
Cx43, Cx50
Rat
Mouse
Human
[24]
[325,336]
[334]
Cortical Corticoids, mineralocorticoids
Androgens
Cx43
Cx43
Rat
Mouse
[24,181]
[182]
Testis Leydig Testosterone Cx43
Cx43, Cx30.2
Rat
Mouse
[337]
[339]
Sertoli Inhibin
Antimullerian hormone
Cx43 Rat [337,338]
Luteal Progesterone Cx43
Cx43, Cx32, Cx26
Cx43
Rat
Sheep
Human, baboon
[223]
[211]
[224]
Ovary Granulosa and theca Estradiol Cx43
Cx43, Cx37, Cx26
Cx43, Cx26, Cx30.3, Cx32
Cx43, Cx37, Cx26, Cx32
Cx43
Mouse, rat
Sheep
Porc
Beef
Human
[198,201]
[211]
[341]
[342]
[340]
Placenta Throphoblast Chorionic gonadotrophin Rat
Human
[144,145]
[146,147]
Pheromone Skin Sebaceous Several in sebum Cx43 Human [239]
Preputial glands Parenchymal Several farnesenes Cx43 Rat [24]
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3.1. GnRH-producing neurons
Several of the two magnocellular and ﬁve parvicellular neuron
types which produce hormones in the paraventricular nucleus of
the hypothalamus are coupled in vertebrates [31–37]. Most of this
coupling is presumably mediated by Cx36 [36,38], the only connexin
which has so far been convincingly shown to be expressed at neuro-
nal gap junction plaques [39]. Other neurosecretory neurons may also
express Cx43 [40,41]. Eventually, GnRH neurons appear not coupled
in the hypothalamus [42–44], but are coupled in the neuromodula-
tory, extrahypothalamic nerve GnRH3 subpopulation [45]. Electro-
physiological studies testing gap junction blockers have indicated
that coupling is implicated in the control of the pulsatile release of
several neuropeptides, including GHRH [46], GnRH [47,48] and
LHRH [49], presumably via the intercellular synchronization of Ca2+
waves [50]. siRNA targeting Cx43 abolished the pulsatile release of
GnRH in cultures of immortalized GT1–7 neuronal cells [41], and
cell-speciﬁc deletion of Cx36 in either prenatal or adult mice induced
alterations in estrous cyclicity, indicating that preoptic kisspeptin
neurons require Cx36 to properly control the GnRH network [43]. Im-
mortalized GnRH-producing neurons of the GT1–7 line, express Cx26
and are coupled [51–53] by channels that appear up-regulated by
cAMP [35]. The primary neurons that intermittently deliver luteiniz-
ing hormone-releasing hormone (GnRH) to the anterior pituitary
are also coupled in vivo [55].
3.2. Dopamine-producing neurons
The secretion of prolactin by the anterior pituitary is suppressed,
under non lactating conditions, by tuberoinfundibular dopamine neu-
rons of the hypothalamus [54]. These neurons oscillate rhythmicallyvia a mechanism that persists during blockade of chemical synaptic
transmission, and it is abolished by gap junction antagonists. The thyro-
tropin-releasing hormone forces these neurons to enter a tonic, not os-
cillatory ﬁring, during which their dopamine release is decreased,
leading to a potent stimulation of prolactin from the pituitary [55].
3.3. Vasopressin- and oxytocin-producing neurons
The magnocellular neurons of the paraventricular and supraoptic
nuclei, which produce vasopressin and oxytocin, are electrically- and
dye-coupled [56–58]. Towards the end of pregnancy, lactation becomes
regulated by a synchronized and high-frequency ﬁring of oxytocinergic
neurons, coupled by Cx32 [59]. The expression of this connexin is low in
the supraoptic nucleus of virgin females, and increases during late preg-
nancy and lactation [59].
3.4. Pineal gland
Pinealocytes have been reported to be coupled by Cx26 channels,
that are up-regulated in vitro by norepinephrine, possibly to improve
melatonin secretion [60].
3.5. Anterior pituitary
The different types of endocrine cells of the anterior pituitary are
coupled [61–64] via channels made predominantly of Cx43 and Cx26
[24,65]. This coupling increases the intercellular synchronization of
Ca2+ transients [51,66]. Ca2+ waves are also propagated throughout the
entire gland via the network of the non endocrine folliculo-stellate cells,
which are extensively coupled by Cx43 channels [63,66,67,68]. In the
horse, the gap junctions of folliculo-stellate appear modulated by the
season and/or photoperiod [69]. Seasonal changes in the expression of pi-
tuitary Cx43 have been associated to changes in prolactin secretion [70].
Fig. 2. Beta cell gap junctions increase after glibenclamide treatment. A–B) Transmis-
sion electron microscopy shows the abundant number of insulin-containing granules
(round clear structures with a dense core) in the beta cells (bc) of a control rat islet
(A), and the marked loss of these organelles after an in vivo treatment with glibencla-
mide (B). This sulphonylurea chronically stimulates insulin secretion. C–D) The corre-
sponding freeze-fracture electron microscopy reveals that control rat beta cells are
connected by small gap junction plaques (C), whereas the glibenclamide-treated, insu-
lin-depleted beta cells feature sizably larger connexon plaques (D). In both cases, most
gap junctions are associated to short tight junction ﬁbrils. Bar, 800 nm in A and B, and
125 nm in C and D.
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The pancreatic islets of Langerhans are minute assemblies (50–
600 μm diameter) of 50–3000 endocrine cells, intermixed with vascu-
lar, connective and immune cells. In humans, about a million of such is-
lets are dispersed in the pancreas, representing in total about 1% volume
of the adult gland, and 1 gwet weight tissue [71]. The insulin-producing
beta cells account for 60–80% of the endocrine population. The remain-
ing endocrine cells are glucagon-producing alpha cells, somatostatin-
producing delta cells, pancreatic polypeptide-producing PP-cells, and
ghrelin-producing epsilon cells [71].
3.6.1. The insulin-producing beta cells
Pancreatic beta cells of rodents and humans are coupled only by
Cx36 (Fig. 1) channels [72–76], which allow for their ionic coupling
throughout each pancreatic islet [77–83], and for a more spatially re-
stricted dye and metabolic coupling [23,84–93], speciﬁcally for nega-
tively charged molecules [86]. This dye coupling is increased in the
islets of transgenic mice whose β-cells are forced to ectopically ex-
press Cx32 or Cx43 in addition to the native Cx36 [23,85,86,94,95],
and also increases in control islets after in vivo treatment with gliben-
clamide, a sulphonylurea which chronically stimulates insulin secre-
tion [86,88,90] (Fig. 2).
To assess the functional role of this coupling, initial experiments
investigated single beta cells, which cannot communicate via gap
junctions. These cells showed increased basal release of insulin
(i.e. the secretion of the hormone observed in the absence of any
stimulus, and which cumulatively accounts for most of the daily insu-
lin production), poor responsiveness to glucose, decreased basal ex-
pression of the 2 insulin genes, decreased proinsulin biosynthesis,
and poor or no elevation in free cytosolic Ca2+ after glucose stimula-
tion [21,22,96–105]. Reestablishment of contacts between betaFig. 1. The insulin-producing beta cells of pancreas are connected by Cx36-made gap
junctions. A) Immunoﬂuorescence detects Cx36 (red) within an endocrine pancreatic
islet (eni) from a control mouse, but not in the adjacent exocrine acini (exa). B) Co-
immunostaining for E-cadherin (green) reveals the spotted distribution of Cx36 at
the membrane of islet cells. C) Transmission electron microscopy at the periphery of
two adjacent beta cells (bc) from a control mouse, identiﬁed by typical, dense core in-
sulin-containing granules, shows the apposition of their membranes at the site of a gap
junction (red arrowheads). Bar, 20 μm in A and B, and 50 nm in C.cells, rapidly restores glucose-induced insulin release, (pro)
insulin biosynthesis, and the elevations in free cytosolic Ca2+
[21,22,90,91,97,98,106]. Beta cell contact also promotes the recruit-
ment of secretory and biosynthetically active beta cells [21,22,96–
99,103]. Beta cells are structurally, biochemically and functionally
heterogeneous, including in terms of the biosynthesis, storage and re-
lease of insulin [21,22,96,100,102,103,108–112]. Under such condi-
tions, a mechanism dependent on cell contact allows for the
recruitment of increasing numbers of secretory cells with both cell
aggregation and the degree of stimulation [21–23,97,98,113]. Lack
of coupling prevents the sharing by β-cells of sparse ion channels
that are critical for proper activation of the stimulus-secretion cou-
pling [114]. Comparable conclusions were reached by exposing isolat-
ed pancreatic islets [115] or whole pancreas [116] to drugs blocking
gap junction channels [117]. Further experiments on insulin-produc-
ing cell lines, showed that the lines which do not release insulin in re-
sponse to a physiological stimulation by glucose, do not express
connexins and are uncoupled [84,107,118,119], whereas cell lines
retaining at least some glucose responsiveness express Cx36 and are
coupled [107]. Remarkably, Cx36 is detected in developing rodents
at the time the ﬁrst insulin-containing beta cells are detected, and
its expression increases around birth, coincidentally with the acquisi-
tion by beta cells of a normal sensitivity to glucose [93].
With the availability of Cx36 null and transgenic mice, the role of
Cx36, and other connexins that are not expressed in native islets,
could be investigated in vivo. Loss of Cx36 [76,120], results in the
uncoupling of beta cells lacking gap junction plaques, and in the asyn-
chrony of the oscillations in free cytosolic Ca2+, which are normally
induced during stimulation by the natural secretagogue glucose
[76]. Cx36-null mice have morphologically normal islets which, how-
ever, do not release insulin in a normal, pulsatile fashion, show an in-
creased basal release of insulin and no signiﬁcant increase in
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[76,120]. These islets also cannot be inhibited as rapidly as control is-
lets when the glucose stimulation ends, due to lack of intercellular
diffusion of hyperpolarizing, inhibitory electrotonic currents [83].
These defects are pancreatic autonomous, inasmuch as similar obser-
vations were made after a beta-cell speciﬁc deletion of Cx36 [120],
and in clones of MIN6 cells that were depleted in Cx36 by an anti-
sense approach [107,118,119,122]. These cells allowed to further es-
tablish that the secretion control achieved by the Cx36 signaling
(Fig. 3) cannot be mediated by other connexins, nor by E-cadherin
[84,118,121], and that excess Cx36 is as deleterious for insulin secre-
tion as the lack of the connexin [84,119,122]. In this perspective, trans-
genic mice forced to express Cx32 in beta cells, show a quite large
increase in the dye coupling of beta cells, and are glucose intolerant,
due to decreased insulin secretory response to supra-physiological glu-
cose stimulation [85].
Cx36-dependent signaling appears also implicated in the life of
beta cells (Fig. 3). Thus, loss of Cx36 sensitizes beta cells toFig. 3. Schematic view of the interactions of beta and alpha cells within pancreatic is-
lets. The scheme depicts 3 beta cells (bc) contacting each other and an adjacent
alpha cell (ac). Experimental data show that most beta cells are coupled (blue colored
cells) via Cx36 channels, which allow for the intercellular synchronization of glucose-
induced Ca2+ transients, the exchange of depolarizing and hyperpolarizing currents,
second messengers and metabolites. These intercellular communications promote
the recruitment of secretory cells as a function of stimulation by secretagogues, and po-
tentiate their secretory output. Cx36-dependent coupling also increases the resistance
of beta cells to cytotoxic conditions. Loss of coupling connections, as a result of either
absence of Cx36, or blockade of the channels this protein makes, results in increased
basal insulin secretion, and beta cell apoptosis. In parallel, the stimulated secretion of
insulin, and the expression of the cognate genes are decreased, as is the recruitment
of secretory cells during exposure to secretagogues. Also, several signaling pathways,
including those dependent of E-cadherin and ephrins, are perturbed. The phenotypic
results of these changes are alterations in both insulin secretion, and beta cell resis-
tance, that are reminiscent of those observed in (pre-)diabetic states.pharmacological and immunological aggressions [95,123,124], in-
cluding the cytokines which induce beta cell apoptosis at the onset
of the auto-immune attack of pancreatic islets that leads to type 1 di-
abetes [95]. Conversely, transgenic mice overexpressing Cx36, or ec-
topically expressing in beta cells Cx32 [85] or Cx43, featured beta
cells which were protected in vitro and in vivo against the same ag-
gressions, possibly because of enlarged coupling [95]. Native Cx36
does not alter islet size or insulin content, whereas the Cx43 isoform
increases both parameters, and Cx32 has a similar effect only when
combined with growth hormone [85,94,125].
3.6.2. The glucagon-producing alpha cells and the somatostatin-producing
delta cells
Pancreatic islets are coordinated assemblies of multiple types of
endocrine cells, which functionally interact with each other. Thus,
the insulin released by beta cells acts on receptors on the closeby,
sometimes adjacent alpha, delta, epsilon and pancreatic polypep-
tide-producing-cells, and, vice versa, glucagon and somatostatin act
on receptors of beta cells [126,127]. There has been an early report
that at least some of these different cell types may be joined by gap
junctions [128]. However, this evidence is indirect, and not supported
by functional coupling data [78,92,129,130]. Thus, whereas secreta-
gogue-induced Ca2+ oscillations are fully synchronized by Cx36
channels among beta cells [76,107], they are asynchronous in alpha
and delta cells of rodent and human islets, both with respect to
each other cell type, and to beta cells [129,130]. The data are consis-
tent with the view that, if the latter cell types were to also express
Cx36, this protein was not involved in the intercellular synchroniza-
tion of Ca2+ transients, as it does in beta cells. The potential coupling
of different islet cell types should be tightly controlled, if not very se-
lective, inasmuch as beta cell function usually parallels that of delta
cells, but is antagonist to that of alpha cells [126,127,131]. Thus, glu-
cose stimulates in parallel insulin and somatostatin release, which
feature synchronous oscillations [129], most likely due to regular
Ca2+ transients [76,107]. Conversely, the nadirs of glucagon oscilla-
tions are antisynchronous to the coincident pulses of insulin and so-
matostatin [129], suggesting lack of simultaneous Cx36-dependent
coupling between these 3 cell types. Still, the ﬁnding that human is-
lets express several connexin transcripts [75], calls for a careful eval-
uation of alternative possibilities. Since all secretory cell types have so
far been found to express at least one connexin species, it is not clear
why alpha and delta pancreatic cells would be an exception. The reg-
ular oscillations they do display in terms of secretory output [131],
rather suggests that these cells may also coupled by some, still elusive
connexin isoform.
In summary, while there is ample evidence that Cx36 plays a sig-
niﬁcant role in the life and secretion of the pancreatic beta cells, little
is known about whether a connexin-dependent signaling is also im-
plicated in the intra-islet integration of the other types of cells, that
collectively form the endocrine pancreas.
4. Cells producing glycoprotein hormones
4.1. Thyroid
The studies implicating gap junctions and connexins in the func-
tioning of the thyroid gland have been reviewed in detail [17,132].
The follicular cells of thyroid express Cx32, Cx26 and Cx43
[24,133,134]. The involvement of connexin signaling in thyroid secre-
tion is supported by the observation that TSH stimulation increases
the coupling of thyrocytes in a time- and concentration-dependent
manner [135], whereas loss of coupling, due to a Cx32 mutation, re-
duces the release of thyroxin [136]. Furthermore, transfection of cell
lines for Cx32 also resulted in increased expression of the thyroglob-
ulin gene [137]. Cx32 and coupling are lost with passages in culture, to-
gether with the ability of the cells to form follicular structures [136,138],
Fig. 4. A) The renin-producing myo-epithelioid cells of kidney are altered after loss of
Cx40. Transmission electron microscopy of the kidney cortex of a control mouse shows
the organization of the juxta-glomerular apparatus. The renin-producing cells (rsc)within
the wall of the afferent arteriole (aa) are located between the convoluted portion of the
distal tube (dt) and the glomerulus (gl). pt= proximal tubule. B–C) Highermagniﬁcation
views show that the renin-containing secretory granules are heterogeneous in shape
within the myo-epitheloid cells of a control mouse (B), and become uniformously round
in the cells of mice lacking Cx40. D–E) Immunoﬂuorescence shows the distribution of
renin in themyo-epitheloid cells (rsc) thatmake the portion of the afferent arteriole abut-
ting each glomerulus (gl) in the kidney of a controlmouse (D). In the kidneys ofmice lack-
ing Cx40, the renin-containing cells (rsc) are more numerous, and several rsc are found
outside the wall of the afferent arteriole. Bar, 8 μm in A, 2 μm in B and C, and 23 μm in
D–E.
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[138] or by transfection of communication-incompetent thyrocytes with
Cx32, but not Cx43 [139].While these data implicate Cx32 in themorpho-
genesis of thyroid follicles, no obvious thyroid defect has been reported in
mice null for the Cx32 gene [140,141]. Communication-incompetent cell
lines derived from thyroid follicles have a reduced proliferation rate
[138], which is modiﬁed after transfection of Cx32, but not Cx43 [142].
Both loss and over-expression of Cx32 modulates the growth of the thy-
roid gland in vivo [143]. Strikingly, early-passage cultures of rat thyroid
cells, which express functional Cx32 channels, are more resistant to
gamma irradiation than later-passage cultures, which express a truncat-
ed, nonfunctional form of Cx32 [136]. In summary, the available evidence
indicates that connexin signaling, speciﬁcally thatmediatedbyCx32, is in-
volved in the control of thyroid cell proliferation, and is under control of
TSH. Further evidence is required to determine whether this coupling
also participates to control thyroid hormone synthesis and release in vivo.
4.2. Placenta
Cx43 connects the cells of placental cytotrophoblast, and these
cells to those of the syncytio-trophoblast [144–146]. The pharmaco-
logical blockade of gap junctions, as well as the antisense interference
with the Cx43 transcript uncouple cytotrophoblast cells, impairing
their fusion and, thus, the formation of the syncytiotrophoblast
[147,148]. These alterations were associated with a decrease in both
the expression of trophoblast-speciﬁc genes coding for β-hCG and
human chorionic somatomammotropin, and the secretion of the for-
mer placental hormone [147,148].
4.3. The renin-producing myo-epithelioid cells of kidney
The epitheloid cells that form the media layer of the afferent arte-
rioles (Fig. 4), when these vessels enter the glomerulus of each neph-
ron in the kidney cortex [149,150], are connected to each other, as
well as to the nearby endothelial cells of the afferent arteriole by mi-
nute gap [151–158], made of Cx40, some Cx37 [155,159,160] and, at
least prenatally, some Cx45 [154]. This pattern is retained by the
transformed cells of the renin-expressing line AS4.1, which also ex-
press Cx40, Cx37, Cx43 and Cx45 [161]. Strikingly, however, renin-
producing cells located outside the afferent arteriole, only express
Cx40 [152,154,155,159,162]. Consistent with these observations,
both primary and transformed renin-producing cells are electrically
and metabolically coupled [154,161,163].
Cx40 null mice feature increased synthesis and release of renin
[164,165], and excessive peripheral vascular resistance, due to the sus-
tained, activation of the renin–angiotensin system [164–169]. Together,
these alterations result in a sizable chronic hypertension of the animals
[164,166–168]. The alterations in renin secretion (Fig. 5), result from
the loss of the normal feedback mechanisms whereby the circulating
levels of angiotensin II and the increased intrarenal blood pressure sup-
press the expression of the renin gene and the release of the hormone
[162,165,167,169]. The inhibitory effect of the macula densa on renin
secretion, which normally operates after a high salt intake, is also atten-
uated in Cx40-deﬁcient mice, whereas the normal regulation by cate-
cholamines is preserved [164,165,167,169]. Increased levels of COX-2
and nNOS also contribute to the excessive renin synthesis and secretion
in the Cx40 null mice [167,169]. Some of these alterations could be im-
proved by treatment of these animals with an inhibitor of the angioten-
sin converting enzyme, which decreases the circulating levels of
angiotensin II, as well as renin synthesis and secretion in Cx40-deﬁcient
mice [164,165].Mice deﬁcient for Cx40 only in renin-producing cells are
also hypertensive, in spite of normal renin expression and plasma levels,
due to an altered, positive regulation of renin secretion by blood pres-
sure [170]. Perfusion of control isolated kidneys with low extracellular
calcium media or gap junction blockers reproduced the high renin out-
put observed in the Cx40 null mice, without modifying the reninsecretion from the kidneys of Cx40-null mice [165], suggesting that
Ca2+ levels [171] and Cx40 channels are both involved in the altered
renin secretion. Accordingly, the expression of Cx40 is altered also in
the kidneys of rats made chronically hypertensive after renal blood
ﬂowwas reduced by clipping of a renal artery [160], leading to a signif-
icant increase in the levels of circulating renin [149,150]. In one study,
conditional Cx45-deﬁcient mice also featured hypertension and in-
creased renin expression [154], whereas in another, similar mice were
normotensive, and displayed normal numbers of renin-producing cells
[172], raising questions as to the actual role of this connexin isoform.
Mice in which Cx45 replaced Cx40, under control of the native Cx40
promoter, have control plasma renin levels and a hypertension signiﬁ-
cantly lower than that of Cx40 null animals [173]. Blockade of angioten-
sin II formation, and the unilateral hypoperfusion of one kidney, which
do not modify the excessive levels of circulating renin in Cx40-deﬁcient
mice, normally increased these plasma levels, as well as blood pressure,
in the Cx45 knock-in animals [173]. The experiments imply that proper
renin secretion is essentially dependent on Cx40 channels, which can
be only partially replaced in this function by Cx45. Loss of Cx37 does
not affect renin secretion, and blood pressure [174,175].
In Cx40 null mice, the renin-producing cells were more numerous
than in the kidneys of control, normotensive littermates [164], and, in
adults, were located within the media of the afferent arterioles, as
well as around these vessels, and in the nearby mesangial and
Fig. 5. Schematic view of the interactions of renin-producing cells within the wall of
the renal afferent arterioles. The scheme depicts 3 renin-producing cells (rsc) contact-
ing each other and adjacent endothelial (ec) and smooth muscle cells (smc). Experi-
mental data show that most renin-producing cells are coupled (blue colored cells) to
each other, as well as to nearby endothelial and smooth muscle cells via Cx40 channels
(blue on the drawing), which allow for the intercellular exchange of currents, and ex-
ogenous tracers permeating gap junctions. These intercellular communications modu-
late the regulated secretion of renin, and the positional imformation that maintains rsc
within the vessel wall. Loss of Cx40 coupling results in a large increase in renin secre-
tion, which associates with the appearance of rsc within the juxtaglomerular mesan-
gium. These changes are Cx40 speciﬁc, inasmuch as they are not observed after loss
of either Cx37 or Cx45, 2 other connexin isoforms expressed by rsc. Of note, the endo-
thelial and smooth muscle cells of the afferent arteriole are further coupled to compan-
ion cells by Cx37 and Cx43 (ec) and Cx43 (smc; violet on the drawing) The phenotypic
results of these changes are alterations in both renin secretion and vascular resistance,
that result in chronic hypertension.
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Comparable observations were made in mice featuring a renin-specif-
ic loss of Cx40 [170]. This anomalous positioning suggests that Cx40,
but not Cx45 [172], is also required for the correct positional informa-
tion of renin-producing cells [170], which typically increase in num-
ber during hypertension [176,177]. The renin-producing cells also
featured smaller and more regular secretory granules than controls
[164] (Fig. 4), further suggesting a shift in their differentiation pat-
tern, as usually observed when cells of the renin lineage are not in
the native, afferent arteriole niche [178]. These experiments have
provided clear, and substantial evidence that Cx40, but not Cx37
and Cx45, play a critical role in the proper control of renin secretion.
Together with the altered expression of Cx43 in the wall of resistance
arteries, the loss of Cx40 results in a sustained and chronic hyperten-
sion, which is reminiscent of the human pathology.5. Cells producing steroid hormones
5.1. Adrenal gland
The role of gap junctions and connexins in the function of the adre-
nal gland has been repeatedly reviewed [19,179,180]. The endocrine
cells of the adrenal cortex are coupled by Cx43 channels [24,181], par-
ticularly in the glucocorticoid- and the androgen-producing regions
[177]. In vitro experiments testing gap junction blockers, have docu-
mented an impaired secretion of cortisol from clusters of adrenal cells,
but not single cells, stimulated by ACTH, but not cAMP [183]. In agree-
ment with these ﬁndings, transfection of adrenal cells with a Cx43 anti-
sense construct also resulted in the inhibition of ACTH-induced steroid
secretion [184]. These data are consistent with the observation that
ACTH increases the expression of Cx43 both in vivo and in vitro [185].
However, and unexpectedly, another gap junction blockerwas reported
to stimulate steroid production, via the activation of both an extracellu-
lar signal-related kinase and a calcium/calmodulin-dependent kinase,
i.e. by two pathways distinct from the protein kinase A-dependent
pathway which normally controls steroidogenesis of adrenal cells
[186]. Adrenocortical cells normally respond to ACTH stimulation by in-
creasing steroid production and Cx43 expression, and by decreasing
their growth [185]. Pharmacological inhibition of their gap junctions
produces the opposite effect, i.e. increased cell growth and decreased
ACTH-stimulated steroidogenesis, without altering the levels of Cx43
[187]. Furthermore, exposure of adrenal cells to a Cx43 antisense
cDNA,which reduced these levels, also resulted in a decreased steroido-
genic response, and in an increase in the cell growth rate [182]. Thus,
Cx43 modulates both the steroidogenic activity and the proliferation
of adrenal cells.
5.2. Testis
The involvement of connexins in the function of the main endo-
crine cell types of testis has been recently reviewed in detail [188].
5.2.1. Inhibin- and antimullerian hormone-producing Sertoli cells
Cx43-made gap junctions connect Sertoli cells to both companion
cells, and to selected germ cells [183]. Cx43 channels contribute to the
functional synchronization of Sertoli cells, and to the reciprocal cou-
pling interactions these cells have with germ cells [189] to ensure
proper spermatogenesis [188]. Accordingly, mice with a Sertoli cell-
speciﬁc loss of Cx43 feature interrupted spermatogeneis at the sper-
matogonia stage, and a proliferation of Sertoli cells [190]. The latter
cells were partly undifferentiated, as revealed by the expression of
the anti-Muellerian hormone, whose pubertal disappearance was
delayed [190]. However, when testes of mice lacking Cx43 were
grafted under the kidney capsules of adult males (to allow for in
vivo maturation) and then stimulated in vitro with cAMP or LH, the
androgen production was similar to that of controls, suggesting that,
in this system, Cx43 was dispensable for steroidogenesis [191]. Still,
Cx43 null mutants show a marked germ cell deﬁciency [191]. siRNA
knockdown of Cx43 in Sertoli cells also slows down the resealing of
the blood-testis barrier after exposure to either low extracellular
Ca2+ or bisphenol A in vitro [192]. In vivo, FSH treatment induces Ser-
toli cells to proliferate and differentiate, irrespective of the presence
of Cx43-dependent coupling, whereas T3, in the presence or absence
of FSH, reduced this proliferation and induced the formation of lumen
in the seminiferous testis tubules, as a function of the maturation of
Cx43 gap junctions [193].
5.2.2. Androgen-producing Leydig cells
Cells derived from the testosterone-producing Leydig cells of tes-
tis express Cx43 [194,195], and are coupled in vitro up to conﬂuence,
under which conditions Cx43 expression and coupling decrease, pre-
sumably as a result of activation of pathways dependent on protein
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served during LH-induced stimulation of testosterone secretion, sug-
gesting a tonic inhibitory inﬂuence of connexin signaling on the
output of the steroid hormone [196]. Mice null for Cx43 feature Ley-
dig cell which, upon grafting in castrated male hosts, produced con-
trol serum levels of androgens, with increased proportions of
17betaHSD and 5alphaR activities, indicating that Cx43 is dispensable
for androgen production [197]. In the absence of Cx43, Leydig cells
are still coupled, suggesting that other connexins contribute to their
gap junctions [197], and/or were induced to compensate the loss of
Cx43. Together, the available evidence indicates that connexin signal-
ing plays an important role, together with the cell-to-cell communi-
cations involving paracrine/autocrine signaling, to ensure proper
control of Sertoli cell synchronization and differentiation and, ulti-
mately, of spermatogenesis. However, whether this signaling is es-
sential for androgenesis remains to be fully elucidated.
5.3. Ovary
The role and function of gap junctions and connexins in the ovarian
follicle has been the subject of a large amount of work, which has been
recently reviewed in a number of excellent reviews [198–203].
5.3.1. Oestrogens-producing granulosa and theca cells
The theca cells derived from the endocrine differentiation of the
granulosa cells, which make the walls of the ovarian follicles, are con-
nected by Cx43 [205,206]. The expression of this connexin varies with
the stage of follicle development, consistent with an involvement of
connexins in the endocrine function of thecal cells [207–209].
In dogs, Cx43 expression changes with the estrus stage in secondary
follicles, but not in primary and antral follicles, indicating that the signal-
ing dependent on this connexin isoform is not involved in the prolonged
follicle and oocyte development which are characteristics of canines
[210]. In the sheep, expression of theca Cx43 decreases 24 h after hCG
treatment [211]. The expression of Cx43 is up-regulated by FSH, and
down-regulated by LH, by PKA- and MAPK-dependent effects on Cx43
translation [212]. In fetal sheep ovaries, Cx26 and Cx32were immunolo-
calized in oocytes, granulosa and theca cells, whereas Cx37 and Cx43
were between oocyte and cumulus cells, and Cx43 was most abundant
in granulosa and theca cells [213]. A maternal diet enriched in selenium
decreased Cx26 and increased Cx43 expression [213]. Cx26 and Cx43
transcripts are altered during the peri-ovulatory period in sheeps, sug-
gesting that the 2 connexins play a role in follicle remodeling [214].
After grafting under the kidney capsule of immunodeﬁcient females,
chimeric ovaries containing either connexin (Cx43 or Cx37) null mutant
oocytes and wild-type granulosa cells, or null granulosa cells and wild
type oocyteswere compared [215]. Ovariesmadewith Cx43 null oocytes
andwild-type granulosa cells featured antral follicles enclosing normally
developing oocytes, as did ovaries made of wild type oocytes and Cx37
null granulosa cells. In contrast, ovaries made with Cx43 null granulosa
cells or Cx37 null oocytes featured defective follicles and oocyte develop-
ment, indicating that lack of Cx43 (in granulosa cells) or Cx37 (in oo-
cytes) is sufﬁcient to largely compromise follicle development and
oogenesis [215]. Patch clamp and dye injection experiments indicate
that folliculogenesis is impaired in the absence of Cx43-dependent
coupling between granulosa cells [216,217]. Gene expression analysis
further supports the view that impaired folliculogenesis in mice lacking
Cx43 is due at least in part to reduced responsiveness of granulosa cells
to oocyte-derived GDF9, stressing an interaction between gap junctional
and paracrine intercellular communication [218].
Cx43 also couples the granulosa cells of cumulus to the oocyte
[202,203,204]. Mice of the Zp3Cre;Gja1(lox/lox) line, which feature
oocytes lacking Cx43, also feature decreased expression of the con-
nexin in cumulus granulosa cell, ovulated normally and form func-
tional corpora lutea [219]. Rat follicle exposed to the gap junction
blocker carbenoxolone result in the meiotic maturation of oocytes,associated to decreased intraoocyte concentrations of cAMP, mimick-
ing the mechanism of LH-induced oocyte maturation [220]. When
Cx43 was ectopically expressed in mouse oocytes lacking Cx37, which
have been shownnot tomaturemeiotically, oocyte growth andmatura-
tion were restored, suggesting that Cx43 can replace Cx37 to couple
oocytes and cumulus cells [221]. Human cumulus cells express Cx43
plaques, as well as cytoplasmic Cx26, Cx30, Cx30.3, Cx32 and Cx40,
and are coupled [222].
5.3.2. Progesterone-producing luteal cells
Cells of corporea lutea are connected by Cx43 [224,225]. Pharma-
cological treatment with agonists and antagonists of cAMP, protein
kinase C and calcium showed that drugs enhancing the coupling of lu-
teal cells increase progesterone secretion, whereas drugs uncoupling
luteal cells decrease steroid release [225]. Consistent with a relation-
ship between connexin signaling and steroid production, the experi-
mental inhibition of Cx43 expression decreases the LH-induced
steroid secretion of luteal cells [226]. Mice lacking Cx37, one of the
connexins that forms gap junctions between oocytes and granulosa
cells, develop numerous abnormal corpora lutea [227]. In vitro, the
levels of Cx43 expression and coupling of luteal cells, which vary
with the day of the estrous cycle and culture conditions, correlate
with progesterone secretion [228]. Furthermore, downregulation of
Cx43 expression by 2 siRNAs, also gradedly decreases progesterone
production [228]. Expression of Cx26, but not Cx32 or Cx43 decreases
during PGF-induced regression of the sheep corpus luteum, suggest-
ing a role in its growth, differentiation, and/or regression [229].
Also, in cows injected with the PGF2alpha analog Cloprostenol,
Cx26, which is not expressed in luteal cells, increases rapidly during
the late luteal phase and after luteal regression [230]. Subsequently,
Cx43 expressionwas distinctly decreased after luteal regression [230].
In sheep, Cx37 is expressed in corporea lutea, at levels dependent on
luteal development, and on PGF2alpha-induced luteal regression, in-
dicating that Cx37 contributes to luteal tissue growth and differenti-
ation [231].
In summary, a large body of experimental evidence supports a
central role of different connexin isoforms, mostly Cx43 and Cx37,
in the in vitro and in vivo control of ovarian folliculogenesis, oocyte
maturation and corpus luteum function, in many of the animal spe-
cies which have so far been investigated.
6. Cells producing catecholamine hormones
The chromafﬁn cells of the adrenal medulla are joined by Cx36-
made gap junctions in all animal species so far investigated, as well
as by Cx43 and Cx50 in some species [232–235]. Cx36 accounts for
the cell-to-cell spreading of the [Ca2+]i transients that are driven by
action potentials [232]. This spreading is enhanced after exposure of
a few cells to nicotine, which also triggers the release of catechol-
amines, indicating that connexin signaling can amplify the secretion
of epinephrine and norepinephrine induced by the synaptic activa-
tion of individual cells [232,233]. Interestingly, both the pharmacolog-
ical blockade of synaptic transmission, as well as the surgical
denervation of the adrenal glands resulted in increased coupling of
chromafﬁn cells, an effect which was also observed in newborn rats at
a time when the synaptic transmission of the adrenal gland had not
yet fully matured [233].These results indicate that the Cx36-dependent
signaling of chromafﬁn cells is tonically inhibited by cholinergic synap-
tic inputs [233]. During cold stress, the expression of Cx36 and Cx43, as
well as the coupling of chromafﬁn cells increase, allowing for the inter-
cellular transmission of action potentials and Ca2+ signaling [235–237].
Electrical stimulation of slices of murine adrenal glands increases the
synchronous secretion of epinephrine and, to a lesser extent of norepi-
nephrine, frommultiple cells. This release is modulated by the signaling
dependent on nicotinic acetylcholine receptors, but not on muscarinic
receptors or gap junctions [238].
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Pheromone-producing glands are considered the phylogenetic
precursors of vertebrate multicellular endocrine systems, combining
the ancestral exocrine mode of secretion with the evolved chemical
signaling, via the vascular or the paracrine route, provided by hor-
mones [5,6]. Whether Cx43, the only connexin so far described in
the pheromone-producing cells of rodents [24] and of their human
sebaceous glands, which form one of their known derivatives [239],
plays any role in the secretion of these volatile chemical messages
has not yet been investigated. However, when viewed in the back-
ground of the short half-life of connexins, the presence of an unusual-
ly high expression of Cx43 between sebocytes [239] suggests some
essential physiological role throughout life time.
8. Connexins contribution to the peripheral action of hormones
Most targets of hormones are at a sizable distance from the gland
that produces the endocrine products, usually preventing the estab-
lishment of connexin-dependent signaling between the secretory
cells and the cognate effector cells. However, connexins may be in-
volved in the cross-talk between these two cell types when these
are in contact. This is the case, for example, of the juxtaglomerular ap-
paratus, the endocrine regions of the renal nephrons, which collec-
tively play a central role in the control of blood pressure [149,150].
The renin-producing cells of the afferent arteriole, which are central
players of this apparatus, share Cx40 junctions with both adjacent
companion cells, and closeby endothelial cells [159]. These endotheli-
al cells are also connected by gap junctions to the smooth muscle cells
of afferent arterioles [159]. Rats made hypertensive after clipping of
one renal artery, show a selective increase in kidney renin and
Cx40, indicating that the connexin is implicated in the control of
renin secretion, and/or in the vasomotor control of renal vessels
[159], a model which also results in changes of aortic Cx43 [152]. In
transgenic mice in which the coding region of Cx43 was replaced by
that of Cx32 [240], wild type and heterozygous mice, which show a
normal distribution of Cx43, become hypertensive as a result of in-
creased plasma renin levels. In contrast, homozygous littermates, in
which Cx32 had fully replaced Cx43, retain a normal blood pressure,
and control levels of circulating renin [241]. The data provide the
ﬁrst support for a mechanism, whereby altered connexin signaling be-
tween endothelial cells modiﬁes the functioning of the renin-secreting
cells (Fig. 5). The case of the juxtaglomerular apparatus may not be
unique. Thus, in the pituitary, the non endocrine folliculo-stellate cells
cross-talk with distant endocrine cells by establishing gap junctions,
that allow for a rapid and extensive propagation of waves of cytosolic
calcium [63,64,68]. This arrangement provides for an efﬁcient mecha-
nism to orchestrate the function of endocrine cell types scattered
throughout the gland.
9. Hormonal control of connexin expression
Many hormones have been reported in a variety of models to af-
fect the transcription, mRNA stability, translation and cytoplasmic
trafﬁcking of connexins, as well as the gating and regulation of the
cell-to-cell channels formed by these proteins. The effects observed
in different studies are variable, and sometimes opposite, reﬂecting
the essential inﬂuence of different cell types, physiological states at
the time of the experiment and different connexin patterns. Since
the previous reviews, which provided a comprehensive coverage of
this topic [10–19], several observations have been made.
9.1. Peptides, second messengers and glycosides
Cells of a GnRH-secreting cell line, which express Cx26, increase
the expression of this connexin and dye coupling after treatmentwith agents increasing cAMP [35]. Throughout the estrous cycle, the
Cx43 channels of luteal cells are modulated by agonists and antago-
nists of cytosolic calcium, cAMP and protein kinase C [225]. cAMP
also increases gap junction plaques made of Cx43 in adrenal cells
[266]. Dibutyril cAMP increases gap junctions of dispersed luteal
cells, throughout the estrous cycle [232].
ACTH increases the coupling of thymic epithelial cells [242]. Infu-
sion of this hormone, but not dexamethasone, increases Cx43 expres-
sion, Cx43 gap junction plaques and cortex size in adrenal glands
[183,184,203].
CRH upregulates the expression of Cx43 and the coupling of
IMR32 neuroblastoma cells and primary astrocytes in organotypic
hippocampal slice cultures, by a mechanism which involves the CRH
receptor, MAPKs and protein kinase A-cAMP response element bind-
ing protein. The extent of oxidative stress-induced protein carbonyla-
tion and cell death inversely correlate with Cx43 levels, and Cx43
contributes to the neuroprotective effects of CRH [243].
Ouabain enhances the expression of Cx32 and the coupling of
MDCK cells [244].
9.2. Steroids
Steroids suppress the expression of Cx26 in the uterine epitheli-
um, and Cx43 in the uterine myometrium and stroma, during the re-
ceptive phase of implantation. Connexin expression then locally
recovers under control of factors secreted by the growing thropho-
blast [245]. During preimplantation, this induction is due to estro-
gens, via the activation of a pathway initiated at estrogen receptors
alpha. During the subsequent embryo implantation and decidualiza-
tion, endometrial connexins are upregulated by an estrogen recep-
tor-independent pathway, possibly implicating catechol estrogen,
prostaglandin F(2α) and interleukin-1β [246].
Hydrocortisone delays gap junction formation in the folliculo-stellate
cells of the anterior pituitary [247]. Treatment of castrated rats with ste-
roids differently changes the number of gap junctions of these cells,
depending on the type of steroid tested and the sex of the animals
[248]. The pancreatic islets of rats made insulin resistant by daily injec-
tions of dexamethasone, feature an increase in the expression of Cx36
and in glucose-stimulated insulin secretion [249],
Ovariectomized rats treated with different ratios of 17beta-estradiol
and progesterone showa dose- and time-dependent regulation of the ex-
pression of uterine Cx26 and Cx43, the prominent connexin of uterine
stroma and myometrium, but not of Cx32 [250]. Estradiol and testoster-
one modulate the expression of Cx43 in the testis of Rana esculenta,
both in vivo and in vitro [251]. 17beta-estradiol alters the phosphorylation
of Cx43 in cardiomyocytes, an effectwhich is inhibited by a speciﬁc estro-
gen receptor antagonist [252]. Progesterone increases Cx43 gap junctions
in luteal cells [253].
9.3. Gonadotrophins
LH and FSHmodulate the coupling of ovarian thecal cells, by regulat-
ing Cx43 expression at the transcriptional, translational and post-transla-
tional levels [254]. The effects of the two gonadotrophins vary as a
function of the developmental stage of the ovarian follicles [255]. LH in-
duces germinal vesicle breakdown in bothmature and immature oocytes
of Bufo arenarum, as long as these cells are coupled to follicle cells, by in-
ducing the cell-to-cell transfer of IP3 or Ca2+ [256]. LH determines the
maturation competence of ﬁsh oocytes by favoring the coupling-
dependent transfer of gonadotrophin-elicited second messengers from
granulosa cells to the oocyte [257]. Short-term exposure to FSH, cAMP
and various steroids alter Cx43 distribution and coupling in fragments
of seminiferous tubules and in a Sertoli cell line [258]. Infusion of
chorionic gonadotrophin does not prevent the excessive expression of
Cx26 in the stroma of baboon uterus with endometriotic lesions, and
the loss of this connexin in the epithelium [259]. FSH uncouples
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FSH and LH on the coupling of cumulus cells depends on the stage of
follicular development and on the presence of the oocyte [261]. FSH
increases coupling in the granulosa cells of small, but not large follicles,
whereas LH and LH+FSH have no effect [261]. LH increases the
coupling of thecal cells of large follicles, whereas FSH or LH+FSH have
no effects [262].
9.4. Thyroid hormones
T3 inhibits the growth of Sertoli cells and increases the levels of
Cx43 and Sertoli cell coupling in the testis, by an actin cytoskeleton-
dependent pathway [263]. Cardiomyocytes of mice over expressing a
dominant negative mutant of thyroid hormone receptor-beta develop
a cardiac hypothyroid phenotype, and feature a reduction in the atrial
expression of Cx40, but not of Cx43, and on atrial depolarization veloc-
ity. Hyperthyroid animals show an increase in both the expression of
Cx40, and the depolarization velocity [264]. Triiodo-L-thyronine and
cAMP, but not 11-ketotestosterone increases the expression of Cx43
in the trout testis in vitro [265].
In summary, most hormones can affect connexin expression, gap
junction formation and functional coupling in a variety of cell types,
even though a direct effect of a hormone on connexins is established
in only rare cases. Rather, the observation that a given hormone may
have different effects in different cell types and/or under different
physiological conditions, suggests that the hormonal effects on con-
nexin signaling may be the result of the pleiotropic cellular events
which hormones usually elicit upon binding to their cognate
receptors.
10. Connexins and endocrine disruptors
Endocrine disruptors are chemicals that, in most species, interfere
with several endocrine systems of, leading to a variety of biological al-
terations andmedical conditions [267,268]. Recent evidence indicates
that these chemicals also affect connexin expression and function.
Thus, the pesticide ioxynil, and its derivative ioxynil octanoate, de-
crease the expression of Cx43, its phosphorylation and the function
of the cell-to-cell channels this connexin makes [269]. It is yet not
established whether these effects account for the effects of these en-
docrine disruptors on tumorigenesis and thyroid alterations.
Bisphenol A decreases the fertility of male rats, increases the post-
implantation loss of embryos in females, and reduces the size of the
newborn litters. The chemical also reduces spermatogenesis and the ex-
pression of Cx43 in the Sertoli cells of testis [270]. Bisphenol-A also re-
duces coupling, but not Cx43 expression, and cell viability in cultures of
epithelial rat BICR-M1Rk cells [271]. Low doses of 17a-ethynylestradiol,
medroxyprogesterone acetate and levonorgestrel, 3 contraceptive ste-
roids discarded in the environment, alter Cx43 trafﬁcking and impair
coupling of testis tubules and a Sertoli cell line in vitro, by a mechanism
which does not involve estrogen receptors [272]. Neonatal exposure to
the anti-androgen ﬂutamide decreases Cx43 gene expression and de-
lays the morphological and functional maturation of adult pig testes,
leading to spermatogenic arrest and Leydig cell hyperplasia
[273].These observations add endocrine disruptors to the long list of
chemicals that, by a large variety of mechanisms, eventually impact
on connexin signaling and coupling [274].
11. Connexins and human endocrine disorders
The abundant information we have summarized provides compel-
ling evidence for an obligatory, if not essential role of connexins in the
proper function of most of endocrine glands, including those (pancre-
atic beta cells and kidney renin cells) that are central to the regulation
of blood glucose and pressure. In turn, this consideration implies that,
by altering the coupling or other forms of interactions between keycells, whether of endocrine, vascular or target nature, some connexin
defect may contribute to the abnormal multi-organ interactions that
characterize endocrine disorders. While there is still little direct evi-
dence for such a scenario in humans, a number of considerations
based on experimental and genetic ﬁndings support a likely pathoge-
netic role of connexins.
11.1. Diabetes
Correlative observations suggest that Cx36-dependent signalingmay
be signiﬁcantly involved in the early pathogenesis of type 1 diabetes,
speciﬁcally in the autoimmune destruction of beta cells by apoptosis
which is thought to bemediated by increased levels of pro-inﬂammatory
cytokines in the islet environment [275]. Thus, Cx36 null mice are sensi-
tized to pharmacological and immune pro-apoptotic conditions, rapidly
loose most of their beta cells and become hyperglycemic as observed in
type 1 diabetes [9,94,95]. Conversely, transgenic mice whose beta cells
speciﬁcally over-express Cx36, or other ectopic connexin isoforms, are
protected against these effects [94,95]. Themechanismof this protection
remains to be fully unraveled. Available data show that it depends on
cell-to-cell contact, and is not due to loss of activity of the pro-apoptotic
cytokines in the islet environment [95]. Rather, a combination of IL-1β,
IFN-γ and TNF-α decreases the expression of the Cx36 protein, by
down-regulating the transcription of the cognate gene [95]. Consistent
with these experimental observations, decreased expression of the
Cx36 transcript has been detected in genome wide scans of type 1 dia-
betes models [276,277].
The alterations in insulin secretion observed in Cx36-null mice
[76] are similar to those observed in prediabetic states (loss of regular
glucose-induced insulin oscillations) and type 2 diabetics (increased
basal release of insulin, no response to stimulation by post-prandial
levels of glucose) [278,279,289], suggesting that Cx36 may be a rele-
vant pathogenetic factor in this disease, which accounts for the vast
majority of the diabetes cases. By necessity, the evidence in support
of this possibility is presently rather indirect, starting with the ﬁnding
that human pancreatic beta cells are functionally connected by Cx36
[75], as observed in rodents. The human GJD2 gene coding for Cx36,
is located on the 14q region of chromosome 15 [280], which is a sus-
ceptibility locus for type 2 diabetes, and the diabetic syndrome [281–
284]. Strikingly, a single nucleotide polymorphism in the coding se-
quence of human GJD2 is pathogenic for a hereditary form of epilepsia
that has a complex pattern of inheritance [285,286], and the same
polymorphism appears unusually frequent in those type 2 diabetics
that show the more reduced insulin secretion. Eventually, the plasma
parameters which are most affected in type 2 diabetes, i.e. elevated
glucose and free fatty acid levels, may further reduce the expression
of the native, residual Cx36. Thus, chronic exposure to high glucose
levels reduces the expression of Cx36 in insulin-producing cell lines
and rat sislets, in a dose- and time-dependent manner, due to a tran-
scriptional down-regulation mediated by the highly conserved cAMP-
responsive CRE element, in the promoter of the Gjd2 gene [124]. CRE
is also repressed by high concentrations of palmitate, in vitro and
in vivo [123]. Eventually, a sulphonylurea which efﬁciently stimu-
lates insulin release from beta cells of type 2 diabetics, also pro-
motes the assembly of Cx36 channels and beta cell coupling
[86,106,287,288].
11.2. Hypertension
Cx40-null mice display a chronic hypertension [164–168], which
mimics several characteristics of the most common forms of the
human disease [149,150], raising the possibility that altered Cx40 sig-
naling be implicated in human hypertension. Several circumstantial
considerations support this possibility. Thus, the similar connexin dis-
tribution in the human and the rodent kidneys [155] is consistent with
the possibility that the sustained activation of the renin–angiotensin
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ber, localization and function of the renin secreting cells, may also occur
in humans lacking normal Cx40 signaling. Strikingly, a single nucleotide
polymorphism (SNP) of the promoter of the Cx40 gene has been associ-
ated with hypertension in selected populations of patients [289–291].
This pathogenic SNP is located close to a Ets-1/NK-box/T-box/SP1 and
a GATA site [291], 2 elements thought to control basal and induced
Cx40 expression [292–295].
The Cx40 null mice also feature alterations in the renal expression
of Cx43 and Cx37 [164], two connexins which are expressed by the
smooth muscle and renin cells of the afferent arteriole, respectively
[296]. However, neither Cx37 null mice nor mice in which Cx43 was
conditionally deleted in the vascular tree, feature increased blood
pressure [172–174], demonstrating that Cx40 predominates in the
pathogenesis of hypertension. Still, because of their distribution and
ability to interact with Cx40, both Cx37 and Cx43 may ﬁnely tune
the cross-talk between the multiple cell types of the juxta-glomerular
apparatus, which sense Na+ concentration, as well as blood ﬂow and
pressure. Accordingly, the in vivo replacement of Cx43 by Cx32 [240],
a connexin isoform which cannot form channels with Cx40, leads to a
down-regulation of renin secretion, and protects the transgenic mice
against a form of experimental, renin-dependent hypertension [241].
Rats made hypertensive after clipping one renal artery, show a selec-
tive increase in kidney renin, as well as in the Cx40 and Cx43 levels
within elastic arteries, implying that these 2 connexins are also impli-
cated in the vasomotor control of vessels, which is perturbed during
hypertension [152,159]. Cx40 and Cx43 are the main connexin iso-
forms of endothelial and smooth muscle cells, and are altered in
both renin-dependent and renin-independent hypertension. These
alterations are expected to impair the proper reactivity of the vessels
to perturbations of the hemodynamic conditions, such as those pro-
vided by increased blood pressure, inasmuch as experimental evi-
dence shows the requirement of junctional channels made of Cx40
in the spreading of hyperpolarization along the arterial bed [297–
302]. This spreading involves communications between adjacent en-
dothelial cells, probably via Cx40–Cx40 channels, as well as between
endothelial and smooth muscle cells, possibly via Cx40–Cx43 chan-
nels [152–159]. Thus, the hypertension observed when Cx40 signal-
ing is impaired cannot be solely accounted for by the perturbed
renin production. Rather, it should also take into account the segmen-
tal vasoconstriction and altered vasomotion of small, resistance arte-
rioles [168,298], which is induced by the sustained activation of the
angiotensin production, itself resulting from the excessive renin
levels. Indeed, blockade of either the angiotensin converting enzyme
or the angiotensin II AT1 receptors reduce, but does not normalize the
blood pressure of Cx40-deﬁcient mice [166]. The necessary participa-
tion of peripheral vascular factors is also supported by the observa-
tion that Cx40 knock-in Cx45 mice exhibit a modest hypertension,
in spite of normal levels of plasma renin [173]. In both cases, the vas-
cular component of the hypertension triggered by the absence of
Cx40, is probably due to an interruption of the cell-to-cell communi-
cation mechanism that normally controls the vasomotor tone
[168,298].
11.3. Metabolic syndrome and diabetic complications
In the context of the so-called metabolic syndrome, type 2 diabe-
tes is associated to lipid disorders and hypertension [303,304]. The
combination of long term hyperglycemia, altered levels of free fatty
acids and hypertension leads to devastating complications that, in
most cases, result from inadequate vascularization of the target or-
gans. Given the widespread distribution of connexins in most tissues
and vessels, and their regulation by several of the metabolic parame-
ters which are altered in the metabolic syndrome, their role should be
evaluated in the development and/or maintenance of this condition,
and of diabetic complications. In vitro studies have shown that achronic increase in the levels of environmental glucose reduces the
communication between both the endothelial and the smoothmuscle
cells of large vessels, via a PKC-dependent phosphorylation of Cx43
[305]. Similar conditions also reduce the expression of Cx43 and the
coupling of microvascular endothelial cells in several tissues, includ-
ing the kidney and the retina that are prominent targets of hypergly-
cemic complications [306,313]. Also, loss of Cx37 accelerates the
development of intimal lesions in the large vessels of apolipoprotein
E-deﬁcient mice, which are prone to develop atherosclerosis [307].
Eventually, connexin alterations are consistent markers of coronary
artery disease [152,308–312] and diabetic nephropathy in humans
[303,313]. These observations suggest that connexins may contribute
to the development and/or maintenance of both micro- and macro-
angiopathies. Also, in rats made hyperglycemic by treatment with
streptozotocin, a drug which acutely kills pancreatic beta cells, a
PKCε-mediated increase in the phosphorylation of Cx43 sensitizes
this connexin to proteolytic degradation, hence reducing its levels be-
tween cardiac myocytes, which results in improper heart contraction
[312,314,315]. A similar alteration was also observed in vitro in the
presence of high glucose levels [316]. This set of experiments suggests
that altered connexin signaling may contribute to the development
and/or maintenance of the remodeled sequence of ventricular con-
traction, which sets the basis for arrhythmias in the diabetic heart.
Eventually, alterations in the expression of Cx43 and/or in Cx43-me-
diated coupling have been observed in a number of peripheral organs
of hyperglycemic, streptozotocin-treated mice, which are frequent
sites of diabetic complications, including lens [317], skin [318] and
corpus cavernosum [319]. The latter study provided the ﬁrst evidence
that selective alterations in the permeability of connexin channels
may also contribute to dysfunction of peripheral organs in chronically
hyperglycemic animals [319]. Zucker fatty rats, which represent a
model of type 2 diabetes, feature increased phosphorylation of renal
Cx43, and decreased expression of Cx37 in renin-secreting cells, com-
pared to age- and strain-matched lean rats [320]. Long term diabetes
is also frequently complicated by peripheral neuropathies, via a vari-
ety of mechanisms which are triggered by the sustained hyperglyce-
mia, and which target central and peripheral neurons, as well as
their supportive glial and Schwann cells [321]. There is now abundant
experimental evidence supporting a physio-pathological role of dif-
ferent connexins in the function of neurons and glial cells in both cen-
tral and peripheral nervous system [322]. The relevance of these
functions in humans is exempliﬁed by the ﬁnding that multiple muta-
tions of Cx32 cause the X-linked form of the Charcot-Marie-Tooth dis-
ease [322], and that a SNP of Cx36, which is the connexin accounting
for electrical synapses [322], is pathogenic in monoclonal juvenile
epilepsia, a form of epileptic disease that shares with type 2 diabetes
a complex, polygenic inheritance [285,286]. Whether connexins are
directly involved in the development, maintenance and evolution of
diabetic neuropathy is beginning to be investigated [313]. Early
changes in the expression of Cx26, Cx32 and Cx43 parallel alter-
ations of autonomous innervation in a model of diabetes-related
bladder dysfunction [323]. In another model, decreased levels of
Cx26 and Cx32 have been described in the perineurium of the pe-
nile nerve of hyperglycemic rats [324].
11.4. Endocrine tumors
As summarized in several sections of this review, increasing evidence
indicates that connexin signaling signiﬁcantly inﬂuences the differentia-
tion, growth and death of different types of endocrine cells, opening the
possibility that abnormal connexin signaling could contribute to the still
obscure pathogenesis of endocrine cancers. So far, only circumstantial,
correlative evidence supports this possibility. A statistically signiﬁcant
association is observed between the expression of Cx26, tumor size
and lymph node metastases in human papillary thyroid cancer and fol-
licular thyroid cancer [325]. Also, the intra-glandular dissemination of
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human papillary carcinomas [325].
Contrasting with the catecholamine-producing cells of the human
adrenal medulla, which normally express Cx50 and some Cx43, the
catecholamine-producing cells of benign pheochromocytomas pre-
dominantly express the former connexin isoform, and those of malig-
nant adrenal pheochromocytomas express Cx26 and Cx32 [235,326].
Mice deﬁcient for Cx32 are sensitized to radiation-induced tumori-
genesis and develop pheochromocytomas more frequently [327]. In
benign adrenocortical adenomas, the number of Cx43-made gap
junctions is reduced in the zona fasciculata, and this number is fur-
ther reduced in the malignant forms of the tumors [328]. Normal
human follicular cells express large amounts of Cx43 in situ and in
vitro, and this expression is markedly reduced, together with cou-
pling, in 4 human ovarian adenocarcinoma cell lines, and in samples
of human serous cystadenocarcinomas [329]. Cx43 expression is
also reduced, if not abolished in human testis inﬁltrated with in situ
carcinomas and in seminomas [185,330,331], an alteration which is
usually associated to increased Cx26 expression [331]. The prolifera-
tion of the tumoral cells of the JKT-1 seminoma line is reduced by
Cx43 over expression [332]. In this case, as in a line derived from a
Leydig tumor, most of Cx43 is cytoplasmic [332,333].
12. Conclusion
With evolution, the production of hormones by endocrine glands
has come under control of a complex signaling network that inte-
grates multiple regulatory mechanisms. The studies summarized
above provide compelling evidence that, in this network, the cell-
to-cell coupling mediated by connexins plays a physiologically rele-
vant role in the proper regulation of hormone gene expression, bio-
synthesis and release, as well as in the maintenance of adequate
numbers of hormone-producing cells. The experimental observations
on a variety of in vitro and in vivo models have unraveled the multi-
faceted signaling that is established by different connexins in most
neuro-endocrine systems, which participate to control a vertebrate
organism. The recent observations made in the basic science laborato-
ry strongly support the view that connexins signiﬁcantly contribute
to proper regulation of several endocrine secretions, and suggests
that a dysregulation of connexin signaling could contribute to some
of the most frequent endocrine disorders of the human clinic. This
possibility calls for further investigations on the molecular organiza-
tion of the underlying signaling, the cellular mechanisms it controls,
and the relationships between the connexin-dependent signaling
and other pathways that concur to regulate the function of endocrine
and target cells. This knowledge is a prerequisite to evaluate the
patho-physiological role of connexins in several endocrine disorders.
In turn, this knowledge will determine the usefulness of a connexin-
targeted approach in the development of innovative therapies of
these diseases.
With regard to the molecular mechanism whereby connexins af-
fect the functions of endocrine cells, future studies should identify
the endogenous signals which permeate connexin channels and act
as second messengers. The task is complicated by the fact that many
of the endogenous signal molecules and metabolites which permeate
connexin channels are also important players for most types of endo-
crine secretions. Therefore, these experiments should also test which
of the permeant ions and molecules is actually dispensable for proper
endocrine cell function. As connexins may signal cells in a variety of
ways, future experiments should further investigate whether connex-
ins may contribute to the proper function of endocrine cells by a
mechanism independent of junctional coupling and, if so, whether
this implies any role of connexin “hemi-channels”, an interaction of
connexins with other proteins and speciﬁc transcription factors, or
their effects on the expression of selected genes [10]. It is certainlyconceivable that connexins may not need to assemble into functional
gap junction channels to exert a biological effect. However, much ad-
ditional data is still required for the validation of the still putative al-
ternative mechanisms. With regard to the cellular mechanisms that
are affected by connexin signaling, we need to understand which sub-
populations of endocrine cells, and possibly target cells, cross-talk
with companion cells and/or with other cell types via connexins.
Also, the hierarchical position of the connexin-dependent pathway,
relative to the other signaling pathways which allow individual cells
to become integrated in a functionally coherent tissue, remains to
be elucidated. With regard to the pathogenesis of endocrine disor-
ders, studies aimed at determining whether qualitative and/or quan-
titative alterations in connexin expression/function participate in a
causal or consequential manner to altered endocrine physiology are
now required in a variety of animal models. This search should not
be limited to genetically encoded disorders, but extend to acquired
and environmental conditions, that have been largely neglected so
far. Obviously, these studies should be extended as much as possible
to patients, at least by taking advantage of the genetic and molecular
biology approaches that are applicable to humans.
These studies should provide important clues as to whether
means to speciﬁcally interact with connexin signaling represent an
avenue worth further exploration for correcting structural and func-
tional alterations of endocrine glands and secretions. This may in-
volve both genetic approaches to correct defects in the expression
of the proteins, and the development of a connexin-targeted pharma-
cology. In turn, the latter development requires automatic methods
for the high-throughput screening of candidate molecules [288]. The
unavailability of such molecules is presently a major limitation in
the connexin ﬁeld. Eventually, it may be worth considering whether
we could take advantage of connexins to foster the implementation
of a cell therapy of some endocrine disorders, e.g. of diabetes. This
therapy implies that the surrogate, insulin-producing cells that
are transplanted in the patients, be able to functionally interact
with the native, resident companion cells, in order to ensure an in-
sulin secretion commensurate with the requirements of the host. In
view of the data so far gathered in laboratory rodents, proper con-
nexin signaling appears as an obligatory requirement to achieve
such a goal.
Given the variety of connexins and connexin-dependent mecha-
nisms and functions, the large number of hormones with exquisite
sensitivity and speciﬁc effects that interact to ensure homeostasis,
still are modulated by the ever changing environmental conditions,
these challenges are exciting, if formidable. They certainly are now
timely, and necessary to foster the development of innovative thera-
pies of several endocrine disorders, which nowadays show an explod-
ing prevalence, worldwide.
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